Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Role of Matrix Metalloproteases in Degradation of ECM01:23

Role of Matrix Metalloproteases in Degradation of ECM

Matrix metalloproteases (MMPs) are enzymes involved in the hydrolysis of proteins and glycoproteins of the extracellular matrix. MMPs are essential for the migration and proliferation of cells through the dense matrix network, throughout embryonic development, and throughout morphogenesis. The first MMP activity discovered was a collagenase in a tadpole's tail undergoing metamorphosis. The active collagen deposition and modifications lead to the morphogenesis of tadpoles into the adult body.
A...
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Anti-Atherogenic Actions of Pomegranate Polyphenol Punicalagin and Its Metabolites: In Vitro Effects on Vascular Cells and In Vivo Atheroprotection by Urolithin A via Anti-Inflammatory and Plaque-Stabilising Mechanisms.

Antioxidants (Basel, Switzerland)·2026
Same author

Resveratrol Mediates Anti-Atherogenic Actions In Vitro and in LDL Receptor-Deficient Mice Fed a High-Fat Diet via Antioxidant, Anti-Inflammatory and Plaque-Stabilising Activities.

Antioxidants (Basel, Switzerland)·2026
Same author

Therapeutic targeting of chronic kidney disease-associated DAMPs differentially contributing to vascular pathology.

Frontiers in immunology·2023
Same author

The Role of Punicalagin and Its Metabolites in Atherosclerosis and Risk Factors Associated with the Disease.

International journal of molecular sciences·2023
Same author

(+)-Catechin Attenuates Multiple Atherosclerosis-Associated Processes In Vitro, Modulates Disease-Associated Risk Factors in C57BL/6J Mice and Reduces Atherogenesis in LDL Receptor Deficient Mice by Inhibiting Inflammation and Increasing Markers of Plaque Stability.

Molecular nutrition & food research·2023
Same author

Anti-Atherogenic Actions of the Lab4b Consortium of Probiotics In Vitro.

International journal of molecular sciences·2023

Related Experiment Videos

ADAMTS proteases: key roles in atherosclerosis?

Rebecca C Salter1, Tim G Ashlin, Alvin P L Kwan

  • 1School of Biosciences, Cardiff University, Museum Avenue, Cardiff, UK CF10 3AX. SalterRC@cardiff.ac.uk

Journal of Molecular Medicine (Berlin, Germany)
|July 24, 2010
PubMed
Summary

ADAMTS proteases are enzymes that break down extracellular matrix. This review explores their roles in inflammation and atherosclerosis, focusing on versican degradation in the vasculature.

Related Experiment Videos

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Pathology

Background:

  • Extracellular matrix (ECM) turnover is regulated by ADAMTS proteases.
  • ADAMTS proteases are implicated in inflammation and atherosclerosis.
  • ADAMTS-4 and -5 are known to degrade aggrecan in osteoarthritis.

Purpose of the Study:

  • To introduce the structure and function of ADAMTS proteases.
  • To review the literature linking ADAMTS proteases to inflammation and atherosclerosis.

Main Methods:

  • Literature review of studies on ADAMTS proteases.
  • Analysis of ADAMTS protease function in ECM degradation.
  • Examination of roles in inflammation and atherosclerosis.

Main Results:

  • ADAMTS proteases degrade specific ECM components.
  • Versican degradation by ADAMTS proteases is key to their role in atherosclerosis.
  • Evidence suggests involvement in inflammatory processes.

Conclusions:

  • ADAMTS proteases are crucial regulators of ECM.
  • Their functions extend to inflammatory diseases like atherosclerosis.
  • Further research is warranted to elucidate specific mechanisms.